PetVivo to Discuss Financial Results for the Fiscal Year End ended March 31, 2022 and Business Update
EDINA, MN, June 29, 2022 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (Nasdaq: PETV and PETVW), an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for animals, announces financial results for its fiscal year ended March 31, 2022.
- Fiscal Year Ended March 31, 2022 (fiscal 2022) Compared to The Year Ended March 31, 2021 (fiscal 2021)
Total Revenues. - Revenues increased to $115,586 in fiscal 2022 compared to $12,578 in fiscal 2021 and consisted of sales to veterinary clinics.
- Cost of sales was $201,154 in fiscal 2022 compared to $10,695 for fiscal 2021.
- Operating expenses increased to $4,970,960 in fiscal 2022 compared to $1,960,871 in fiscal 2021.